Multiple Myeloma
Multiple Myeloma
Advertisement
Cailin ConnerMultiple Myeloma | September 5, 2024
Significant delays in diagnosing multiple myeloma exist.
Read More
Cailin ConnerMultiple Myeloma | September 3, 2024
Talquetamab is a promising treatment for relapsed multiple myeloma, however, it presents unique side effects.
Cailin ConnerMultiple Myeloma | September 1, 2024
In MM patients, prescription delays were linked to Black race, older age, inpatient diagnosis, and severe renal impairment.
Cailin ConnerMultiple Myeloma | August 30, 2024
There is a disproportionately high MM incidence and mortality among non-Hispanic Black Americans.
Sikander Ailawadhi, MDMultiple Myeloma | July 29, 2024
Dr. Ailawadhi explores ways that researchers are designing trials to address racial disparities in enrollment.
Sikander Ailawadhi, MDMultiple Myeloma | July 24, 2024
Dr. Ailawadhi explained how oncologists should consider racial differences when approaching clinical care.
Rebecca AraujoMultiple Myeloma | July 8, 2024
Inpatient treatment comprised 48% of medical costs in patients with renal impairment.
Cailin ConnerMultiple Myeloma | July 3, 2024
Patients with multiple myeloma in the US Military Health System had significantly better survival rates.
Rebecca AraujoMultiple Myeloma | June 24, 2024
Race was associated with the dollar amount patients were willing to pay for treatment each month.
Cailin ConnerMultiple Myeloma | June 22, 2024
Obesity significantly increases the risk of multiple myeloma, especially in Black populations.
Cecilia BrownMultiple Myeloma | June 6, 2024
These factors may drive disparities in care for Black patients with multiple myeloma.
Cecilia BrownMultiple Myeloma | June 4, 2024
A new study shows why it's important for nurses to be aware of how social determinants of health affect medication adherence.
Cecilia BrownMultiple Myeloma | June 4, 2024
It's important for nurses to recognize opportunities to address racial disparities in hospice use and access.
Cecilia BrownMultiple Myeloma | June 2, 2024
Clinical trial knowledge is related to the likelihood of participation.
Rebecca AraujoMultiple Myeloma | May 31, 2024
More than 70% of patients aged 70 years and older with multiple myeloma prioritized functional independence as important.
Cailin ConnerMultiple Myeloma | May 29, 2024
Stem cell transplant utilization remains suboptimal and marked by racial-ethnic disparities.
Cecilia BrownMultiple Myeloma | May 10, 2024
The study results underscore the importance of equitable treatment access for all patients.
Cecilia BrownMultiple Myeloma | May 9, 2024
New research shows there is increasing racial disparity in treatment utilization over time among patients with MM.
Cecilia BrownMultiple Myeloma | May 8, 2024
A new study shows why it’s critical for nurses to be aware of how social determinants of health affect patients with MM.
Cecilia BrownMultiple Myeloma | May 7, 2024
A team developed a community-wide MM screening program for those who are Black and 50 years of age or older.
Advertisement
Advertisement
Advertisement
Latest News

November 21, 2024